OSI Pharmaceuticals, Inc. 41 Pinelawn Road Melville, NY 11747 T 631.962.2000 F 631.962.2023 www.osip.com December 17, 2008 Linda E. Amper, Ph.D. c/o OSI Pharmaceuticals, Inc. 41 Pinelawn Road Melville, NY 11747 Re: Amendment to Change of Control...
Exhibit 10.51
OSI Pharmaceuticals, Inc.
00 Xxxxxxxx Xxxx
Xxxxxxxx, XX 00000
T 631.962.2000 F 631.962.2023
xxx.xxxx.xxx
00 Xxxxxxxx Xxxx
Xxxxxxxx, XX 00000
T 631.962.2000 F 631.962.2023
xxx.xxxx.xxx
December 17, 2008
Xxxxx X. Xxxxx, Ph.D.
c/o OSI Pharmaceuticals, Inc.
00 Xxxxxxxx Xxxx
Xxxxxxxx, XX 00000
c/o OSI Pharmaceuticals, Inc.
00 Xxxxxxxx Xxxx
Xxxxxxxx, XX 00000
Re: Amendment to Change of Control Letter Agreement
Dear Xxxxx:
This letter shall serve to amend your letter agreement dated December 4, 2007 (the
“Agreement”) by adding to such Agreement the following provisions:
3. Section 409A.
(i) To the extent you would be subject to the additional 20% tax imposed on certain
deferred compensation arrangements pursuant to Section 409A of the U.S. Internal Revenue
Code (“Section 409A”), as a result of any provision of this Agreement, such provision shall
be deemed amended to the minimum extent necessary to avoid application of such tax and the
parties shall promptly execute any amendment reasonably necessary to implement these
provisions.
(ii) With respect to payments under this Agreement, for purposes of Section 409A, each
severance payment and COBRA continuation reimbursement payment will be considered one of a
series of separate payments.
(iii) You will be deemed to have a termination of employment for purposes of
determining the timing of any payments that are classified as deferred
compensation only upon a “separation from service” within the meaning of Section 409A.
(iv) If at the time of your separation from service, (i) you are a specified employee
(within the meaning of Section 409A and using the identification methodology selected by OSI
from time to time), and (ii) OSI makes a good faith determination that an amount payable to
you constitutes deferred compensation (within the meaning of Section 409A) the payment of
which is required to be delayed pursuant to the six-month delay rule set forth in Section
409A in order to avoid taxes or penalties under Section 409A (the “Delay Period”), then OSI
will not pay such amount on the otherwise scheduled payment date but will instead pay it in
a lump sum on the first business day after such six-month period. To the extent that any
benefits to be provided during the Delay Period are considered deferred compensation under
Section 409A provided on account of a “separation from service,” and such benefits are not
otherwise exempt from Section 409A, you shall pay the cost of such benefits during the Delay
Period, and OSI shall reimburse you, to the extent that such costs would otherwise have been
paid by OSI or to the extent that such benefits would otherwise have been provided by OSI at
no cost to you, OSI’s share of the cost of such benefits upon expiration of the Delay
Period, and any remaining benefits shall be reimbursed or provided by OSI in accordance with
the procedures specified herein.
(v) Any amount that you are entitled to be reimbursed under this Agreement, including
the payment of excise taxes and gross-up amounts, will be reimbursed to you as promptly as
practical and in any event not later than the last day of the calendar year after the
calendar year in which the expenses are incurred, and the amount of the expenses eligible
for reimbursement during any calendar year will not affect the amount of expenses eligible
for reimbursement in any other calendar year.
(vi) Unless your Agreement provides a specified and objectively determinable payment
date to the contrary, any payment of compensation will be made, in any event, by March 15 of
the calendar year following the year with respect to which such compensation is earned.
Sincerely yours,
/s/ Xxxxxxx X. Xxxx
Xxxxxxx X. Xxxx
Senior Vice President, General Counsel
And Secretary
Senior Vice President, General Counsel
And Secretary
Accepted and Agreed:
/s/ Xxxxx X. Xxxxx | ||||
Xxxxx X. Xxxxx, Ph.D. | ||||